Clinical Trial Phases Explained

The Four Phases of Clinical Trials

Before a new treatment reaches patients, it goes through a rigorous testing process divided into phases. Each phase has a different purpose, participant group, and level of risk.

Phase 1: Safety Testing

• Purpose: Test safety, dosage, and side effects of a new treatment for the first time in humans.
• Participants: Usually 20–80 healthy volunteers (sometimes patients with serious conditions).
• Duration: Several months.
• Compensation: Typically the highest ($1,000–$10,000+) due to the unknown risk profile.
• Risk level: Highest, as the treatment hasn't been tested in humans before.

Phase 2: Effectiveness Testing

• Purpose: Evaluate whether the treatment works for the intended condition and continue safety monitoring.
• Participants: 100–300 people who have the target condition.
• Duration: Several months to 2 years.
• Compensation: Moderate ($500–$5,000).
• Risk level: Moderate — preliminary safety data exists from Phase 1.

Phase 3: Comparing to Standard Treatment

• Purpose: Confirm effectiveness and monitor side effects in a large group, comparing to existing treatments or placebo.
• Participants: 1,000–3,000+ patients.
• Duration: 1–4 years.
• Compensation: Lower ($100–$2,000) but treatment is more established.
• Risk level: Lower — extensive prior testing.

Phase 4: Post-Market Surveillance

• Purpose: Monitor long-term safety and effectiveness after FDA approval.
• Participants: Thousands of patients using the approved treatment.
• Compensation: Usually modest ($50–$500 per visit).
• Risk level: Lowest — treatment is already FDA-approved.

Which Phase Is Right for You?

Your choice depends on your risk tolerance, time availability, and health status. Use GetPaidClinicalTrials to filter by study phase and find the right fit.

Browse Trials by Condition

Find Trials by City